2021 marks a new era for Alzheimer's therapeutics
Lancet Neurol
.
2022 Jan;21(1):3-4.
doi: 10.1016/S1474-4422(21)00412-9.
Author
Kejal Kantarci
1
Affiliation
1
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: kantarci.kejal@mayo.edu.
PMID:
34942134
PMCID:
PMC8687665
DOI:
10.1016/S1474-4422(21)00412-9
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Alzheimer Disease* / drug therapy
Amyloid beta-Peptides
Humans
Substances
Amyloid beta-Peptides